Winsan (Chengdu) Medical Science and Technology Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 12.32 million compared to CNY 8.58 million a year ago. Revenue was CNY 17.08 million compared to CNY 13.36 million a year ago.

Net loss was CNY 5 million compared to net income of CNY 1.58 million a year ago. Basic loss per share from continuing operations was CNY 0.0147 compared to basic earnings per share from continuing operations of CNY 0.005 a year ago. Diluted loss per share from continuing operations was CNY 0.0147 compared to diluted earnings per share from continuing operations of CNY 0.005 a year ago.